retinaSEES
Multimodal Laser Retinal Therapy
retinaSEES is our approach to treating intermediate age-related macular degeneration (AMD). This technique uses light therapy to counteract the damaging effects of AMD and promote tissue health, which can help to retain vision.
Clinical Need
AMD is a leading cause of irreversible visual impairment and blindness globally, particularly affecting individuals over the age of 601.
Over
200M
people are impacted by neovascular age-related macular degeneration (AMD), which ranks among the most prevalent causes of blindness2.
Over
10%
of persons with early-stage Dry AMD will progress to the more severe forms of the disease, leading to significant vision loss blindness3.
retinaSEES Stands Out
Multi-Mode Light Stimulation
Using light technologies, including lasers, retinaSEES aims to stimulate the eye through the promotion of retina-tissue homeostasis.
Standardised Therapeutic Parameters
Through standardised and specific procedure parameters, retinaSEES aims to achieve consistent and effective treatment outcomes.
Compact and Intuitive Design
Designed to ensure patient comfort and clinician ease of use, retinaSEES supports a smooth and intuitive interaction in practice.
We recognise that the quality of any medical solution is also defined by its delivery procedures and the corresponding user experience.
Non-Invasive Approach
Focused on minimising patient discomfort and burden while ensuring efficient treatment delivery, retinaSEES offers light therapy sessions lasting less than 2 minutes.
Its optical arrangement is fully contactless except for the chinrest, allowing treatment without physical contact and enhancing overall comfort and convenience.
Real-Time Retina Alignment Monitoring
The retinaSEES therapeutic console provides continuous alignment feedback for safe and homogeneous treatment sessions, optimizing patient care and outcomes.